Skip to main content
Editas Medicine, Inc. logo

Editas Medicine, Inc. — Investor Relations & Filings

Ticker · EDIT ISIN · US28106W1036 LEI · 5299000AON4Q9NT2JE42 US Professional, scientific and technical activities
Filings indexed 679 across all filing types
Latest filing 2018-02-16 Director's Dealing
Country US United States of America
Listing US EDIT

About Editas Medicine, Inc.

https://www.editasmedicine.com/

Editas Medicine, Inc. is a clinical-stage genome editing company focused on developing transformative medicines for serious diseases using CRISPR technology. The company's mission is to discover, develop, and commercialize durable, precision genomic therapies that can correct the underlying genetic causes of various conditions. Its proprietary platform enables the precise revision, removal, or replacement of DNA. Editas Medicine's research and development pipeline is concentrated on creating both in vivo (in-body) and ex vivo (out-of-body) gene-edited medicines to treat a broad class of diseases, with a focus on rare genetic disorders.

Recent filings

Filing Released Lang Actions
FORM 3 -
Director's Dealing
2018-02-16 English
FORM 4 -
Director's Dealing
2018-02-16 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 14, 2018, reporting the appointment of a new director, Jessica Hopfield, to the Board of Directors of Editas Medicine, Inc. It details her background, committee assignment, and compensation. The key section is Item 5.02, which pertains to the departure or election of directors or officers. There is no financial data or report content, only an announcement of a board management change. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 5794 characters, sufficient to contain detailed information about the management change, not just a brief announcement or report publication notice.
2018-02-16 English
SC 13G/A
Major Shareholding Notification
2018-02-14 English
EDITAS MEDICINE, INC.
Major Shareholding Notification
2018-02-14 English
SC 13G/A
Major Shareholding Notification
2018-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.